Blog

Streamlined gene-to-antibody workflows boost yields. Biointron outlines high-throughput recombinant production that accelerates biologics programs.

Biointron’s Antibody ABCs video series educates scientists with 31 concise videos simplifying antibody concepts for students and professionals.

Recombinant monoclonal antibodies ensure precision. Biointron explains their production and roles in research, diagnostics, and therapeutic applications.

Scaling antibody discovery services is critical. Biointron supports global biologics development with expertise in discovery, engineering, and CRO services.

AI is accelerating antibody discovery. Biointron highlights how machine learning drives design, optimization, and faster therapeutic development.

ADCs are transforming oncology. Biointron shares 10 key facts explaining their mechanisms, advantages, and growing therapeutic applications.

Bispecific antibodies are reshaping pipelines. Biointron reviews leading developers driving bsAb innovation and global therapeutic progress.

Custom bispecific antibody production meets research needs. Biointron tailors bsAb solutions to accelerate therapeutic discovery and validation.

Antibodies are emerging treatments for muscular disorders. Biointron highlights their role in Duchenne and other inherited disease therapies.

Ulcerative colitis therapies are advancing. Biointron reviews milestones in antibody drug research shaping treatment of UC and related conditions.

Antibody-oligonucleotide conjugates bring precision to therapy. Biointron explores their design, mechanisms, and potential in next-gen therapeutics.

Fully human antibody platforms are revolutionizing discovery. Biointron highlights how these systems reduce immunogenicity and improve therapeutic pipelines.